The Impact of POCUS on Treatment Planning and Prognosis in the ICU
Launched by DÖNDÜ GENC MORALAR · Sep 23, 2024
Trial Information
Current as of July 15, 2025
Completed
Keywords
ClinConnect Summary
### Detailed Description for Clinical Trials
This prospective observational study focuses on the routine use of point-of-care ultrasound (POCUS) in the intensive care unit (ICU) and its impact on diagnosis, treatment decisions, and patient outcomes. Bedside ultrasound is increasingly recommended in ICU settings because it provides non-invasive, repeatable, and immediate diagnostic information that can guide the management of critically ill patients.
Upon admission, all ICU patients will undergo an initial assessment, including routine tests such as the APACHE-II score, which helps to esti...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients over the age of 18 who are admitted to intensive care
- • Patients who have been in intensive care for more than 5 days
- Exclusion Criteria:
- • Being pregnant
- • Patients with head trauma
- • Acute renal failure
About Döndü Genc Moralar
Döndü Genc Moralar is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and rigorous methodologies. With a focus on ethical standards and regulatory compliance, the organization collaborates with a diverse network of healthcare professionals and institutions to facilitate the development of groundbreaking therapies. By prioritizing patient safety and data integrity, Döndü Genc Moralar aims to contribute significantly to the scientific community and enhance the quality of care across various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported